Ausgabe 5/2019
Inhalt (18 Artikel)
Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan
Satoru Senoo, Kiichiro Ninomiya, Katsuyuki Hotta, Katsuyuki Kiura
Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin
Satoshi Hamauchi, Tomoya Yokota, Takatsugu Mizumachi, Yusuke Onozawa, Hirofumi Ogawa, Tsuyoshi Onoe, Tomoyuki Kamijo, Yoshiyuki Iida, Tetsuo Nishimura, Tetsuro Onitsuka, Hirofumi Yasui, Akihiro Homma
STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy
Wei-Jing Gong, Li-Yun Ma, Lei Hu, Yong-Ning Lv, Hong Huang, Jia-Qiang Xu, Dan-Dan Huang, Rui-Jie Liu, Yong Han, Yu Zhang, Shao-Jun Shi, San-Lan Wu
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC
Shunichi Sugawara, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Hiroshi Nokihara, Yuichiro Ohe, Makoto Nishio, Toshiaki Takahashi, Koichi Goto, Makoto Maemondo, Yukito Ichinose, Takashi Seto, Hiroshi Sakai, Akihiko Gemma, Fumio Imamura, Masato Shingyoji, Hideo Saka, Akira Inoue, Koji Takeda, Isamu Okamoto, Katsuyuki Kiura, Satoshi Morita, Tomohide Tamura
Interaction of H. pylori with toll-like receptor 2-196 to -174 ins/del polymorphism is associated with gastric cancer susceptibility in southern China
Jin Huang, Jun-Jie Hang, Xiang-Rong Qin, Jian Huang, Xiao-Yong Wang
Risk factors for cardiovascular mortality in patients with colorectal cancer: a population-based study
Apostolos Gaitanidis, Michail Spathakis, Christos Tsalikidis, Michail Alevizakos, Alexandra Tsaroucha, Michail Pitiakoudis
Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer
Tomoyasu Yoshihiro, Hitoshi Kusaba, Akitaka Makiyama, Kazuma Kobayashi, Masato Uenomachi, Mamoru Ito, Yasuhiro Doi, Kenji Mitsugi, Tomomi Aikawa, Kotoe Takayoshi, Taito Esaki, Hozumi Shimokawa, Kenji Tsuchihashi, Hiroshi Ariyama, Koichi Akashi, Eishi Baba
mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival
Masamichi Yasuno, Hiroyuki Uetake, Megumi Ishiguro, Nobuyuki Mizunuma, Takamichi Komori, Go Miyata, Akio Shiomi, Tatsuo Kagimura, Kenichi Sugihara
External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model
Pawel Chrom, Jakub Zolnierek, Lubomir Bodnar, Rafal Stec, Cezary Szczylik
Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy
Yoshitaka Itami, Makito Miyake, Yoshihiro Tatsumi, Daisuke Gotoh, Shunta Hori, Yousuke Morizawa, Kota Iida, Kenta Ohnishi, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Nobumichi Tanaka, Keiji Shimada, Shuya Hirao, Kiyohide Fujimoto
Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration
Keisuke Shigeta, Takeo Kosaka, Hiroshi Hongo, Yoshinori Yanai, Kazuhiro Matsumoto, Shinya Morita, Ryuichi Mizuno, Toshiaki Shinojima, Eiji Kikuchi, Mototsugu Oya
Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration
Keisuke Shigeta, Takeo Kosaka, Hiroshi Hongo, Yoshinori Yanai, Kazuhiro Matsumoto, Shinya Morita, Ryuichi Mizuno, Toshiaki Shinojima, Eiji Kikuchi, Mototsugu Oya
Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases
Hirotsugu Uemura, Hiroji Uemura, Satsohi Nagamori, Yoshiaki Wakumoto, Go Kimura, Hiroaki Kikukawa, Akira Yokomizo, Atsushi Mizokami, Takeo Kosaka, Naoya Masumori, Yoshihide Kawasaki, Junji Yonese, Yasutomo Nasu, Satoshi Fukasawa, Takayuki Sugiyama, Seigo Kinuya, Makoto Hosono, Iku Yamaguchi, Takashi Akagawa, Nobuaki Matsubara
Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?
Kosuke Yoshida, Hiroaki Kajiyama, Masato Yoshihara, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kimihiro Nishino, Fumi Utsumi, Kaoru Niimi, Shiro Suzuki, Fumitaka Kikkawa
A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors
Fumiaki Isohashi, Tadao Takano, Mamiko Onuki, Takahide Arimoto, Naoki Kawamura, Ryusuke Hara, Yoshiaki Kawano, Yukinobu Ota, Haruo Inokuchi, Hidenori Shinjo, Toshiaki Saito, Satoe Fujiwara, Takashi Sawasaki, Ken Ando, Koji Horie, Hiroyuki Okamoto, Naoya Murakami, Yoko Hasumi, Takahiro Kasamatsu, Takafumi Toita
Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study
Jinsoo Rhu, Chan Woo Cho, Kyo Won Lee, Jae Berm Park, Sung Joo Kim
c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia
Hiroyuki Kubo, Osamu Imataki, Yukiko Hamasaki Kubo, Makiko Uemura, Norimitsu Kadowaki
Clinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patients
Satoko Ito, Haruyuki Ito, Noriyuki Sato, Yasuo Hirayama, Toshihiko Kusakabe, Takeshi Terui, Kunihiko Ishitani